Efficacy and safety of Chinese herbal medicine for vascular dementia
Open Access
- 1 May 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine: Case Reports and Study Protocols
- Vol. 3 (5) , e0224
Abstract
Introduction: As a common type of clinical dementia, the prevalence rate of vascular dementia (VaD) increased rapidly in recent years, damaging both patients’ health and social-economic prospect. There is currently no effective treatment for VaD, though western medicines can slightly improve patients’ cognitive function, but not brought a significant improvement in daily life ability. Chinese herbal medicine (CHM) has been widely employed to treat dementia for more than 2000years in China. Despite the proliferation of relevant literature, there is still a lack of evidence to prove the effectiveness and safety of such therapy. Therefore, this systematic review and meta-analysis protocol is aimed to assess the efficacy and safety of CHM for VaD. Methods and analysis: Six English databases (PubMed, Web of Science, Embase, Springer, CENTRAL and WHO International Clinical Trials Registry Platform) and 4 Chinese databases (Wan fang Database, Chinese Scientific Journals Database , China National Knowledge Infrastructure Database and Chinese Biomedical Literature Database ) will be searched from the inception to July 1st, 2020. Randomized controlled trials, which participants with VaD receiving various CHM therapy versus control group, will be included in this study. Two researchers will independently obtain data, screen eligible trials, and evaluate the quality of literature. Any disagreement will be settled by a discussion with the third investigator. A comprehensive meta-analysis will be conducted using the Cochrane collaboration software (Review Manager 5.3). Ethics and dissemination: Since this article is a protocol that does not involve patients and personal information collection, ethical approval is therefore not required. This systematic review will be published in a peer-reviewed journal, presented at conferences, and will be shared on social media platforms. The review will be disseminated in a peer-reviewed journal or conference presentation. INPLASY registration number: INPLASY 202210098.Keywords
This publication has 15 references indexed in Scilit:
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet, 2016
- Influence of Amyloid-β on Cognitive Decline After Stroke/Transient Ischemic AttackStroke, 2015
- Can Chinese Herbal Medicine Adjunctive Therapy Improve Outcomes of Senile Vascular Dementia? Systematic Review with Meta-analysis of Clinical TrialsPhytotherapy Research, 2015
- Vascular dementiaThe Lancet, 2015
- Diagnostic Criteria for Vascular Cognitive DisordersAlzheimer Disease & Associated Disorders, 2014
- The prevalence of dementia in urban and rural areas of ChinaAlzheimer's & Dementia, 2013
- Vascular Contributions to Cognitive Impairment and DementiaStroke, 2011
- Feature Extraction and Strategy of Analyzing Structural Neuroimaging in Dementia2008
- Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trialsThe Lancet Neurology, 2007
- The incidence of dementiaNeurology, 1998